Sean Mackay Standard Biotools Inc. (LAB) insider trading activity

LAB Quotes by TradingView

Sean Mackay is SVP & Chief Business Officer of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 819,157 shares of LAB, which is worth approximately $876,497. The most recent transaction as insider was on May 28, 2025, when has been sold 23,919 shares (Common Stock) at a price of $1.09 per share, resulting in proceeds of $26,071. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 819K
n/a 3M change
n/a 12M change
Total Value Held $876,497

Sean Mackay Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 28 2025
SELL
Payment of exercise price or tax liability
$26,071 $1.09 p/Share
23,919 Reduced 2.84%
819,157 Common Stock
May 23 2025
SELL
Open market or private sale
$12,423 $0.94 p/Share
13,217 Reduced 1.54%
843,076 Common Stock
May 22 2025
SELL
Open market or private sale
$12,536 $1.0 p/Share
12,536 Reduced 1.44%
856,293 Common Stock
May 21 2025
SELL
Open market or private sale
$13,223 $1.03 p/Share
12,838 Reduced 1.46%
868,829 Common Stock
Mar 21 2025
BUY
Grant, award, or other acquisition
-
281,667 Added 24.21%
881,667 Common Stock

Also insider at

ISO
IsoPlexis Corp Healthcare
Chief Executive Officer
SM

Sean Mackay

SVP & Chief Business Officer
Branford, CT

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LAB